News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Invitrogen Corporation (IVGN) Teams with Genisphere to Advance Epigenetic Research


2/27/2008 8:50:43 AM

CARLSBAD, Calif. & HATFIELD, Pa.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, will become the exclusive provider of fluorescent microRNA microarray labeling kits using Genisphere Inc.’s 3DNA® dendrimer signal amplification technology, based on the terms of a new license agreement. This technology, combined with Invitrogen’s Alexa Fluor® fluorescent dyes, is now commercialized in the new NCode™ Rapid miRNA Labeling System, available from Invitrogen.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES